Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sorbie Investments is a private investment firm based in London, United Kingdom, that specializes in providing structured equity financing and capital solutions to growth-oriented companies. The firm has established a significant footprint within the life sciences, biotechnology, and healthcare sectors, often serving as a strategic financial partner for small-cap and mid-cap public entities. Sorbie is recognized for its flexible funding models, such as equity subscription facilities, which enable biotech companies to secure the necessary capital for advancing clinical trials and research programs. Its investment portfolio includes a diverse range of companies focused on innovative therapies in oncology, immunology, and rare diseases. By providing reliable access to capital, Sorbie Investments plays a crucial role in the development and commercialization of next-generation medical technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sorbie Investments.